BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12454685)

  • 1. Implications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease.
    Bivalacqua TJ; Champion HC; Hellstrom WJ
    Int J Impot Res; 2002 Oct; 14(5):345-52. PubMed ID: 12454685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat.
    Bivalacqua TJ; Champion HC; Leungwattanakij S; Yang DY; Hyun JS; Abdel-Mageed AB; Sikka SC; Kadowitz PJ; Hellstrom WJ
    J Androl; 2001; 22(3):497-506. PubMed ID: 11330651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History, epidemiology, and clinical presentation of Peyronie's disease.
    Hellstrom WJ
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S91-2. PubMed ID: 14551584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peyronie's disease: advances in basic science and pathophysiology.
    Bivalacqua TJ; Purohit SK; Hellstrom WJ
    Curr Urol Rep; 2000 Dec; 1(4):297-301. PubMed ID: 12084307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression.
    Bivalacqua TJ; Diner EK; Novak TE; Vohra Y; Sikka SC; Champion HC; Kadowitz PJ; Hellstrom WJ
    J Urol; 2000 Jun; 163(6):1992-8. PubMed ID: 10799245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease.
    Gonzalez-Cadavid NF; Rajfer J
    Nat Clin Pract Urol; 2005 Jun; 2(6):291-7. PubMed ID: 16474811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereological and biochemical analysis of muscular and connective tissue components in the penile corpus cavernosum adjacent to the fibrous plaque of Peyronie's disease.
    Costa WS; Rebello SB; Cardoso LE; Cavalcanti AG; Sampaio FJ
    BJU Int; 2009 Jan; 103(2):212-6. PubMed ID: 18782314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression in Peyronie's disease.
    Gonzalez-Cadavid NF; Magee TR; Ferrini M; Qian A; Vernet D; Rajfer J
    Int J Impot Res; 2002 Oct; 14(5):361-74. PubMed ID: 12454687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie's disease.
    Davila HH; Magee TR; Vernet D; Rajfer J; Gonzalez-Cadavid NF
    Biol Reprod; 2004 Nov; 71(5):1568-77. PubMed ID: 15240426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective analysis of 16S rDNA as a highly sensitive marker for bacterial presence in Peyronie's disease plaques.
    Hauck EW; Domann E; Hauptmann A; Weidner W; Chakraborty T; Hossain HM
    J Urol; 2003 Nov; 170(5):2053-6. PubMed ID: 14532852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of traction therapy for Peyronie's disease: present and prospect].
    He ZH; Lu YP
    Zhonghua Nan Ke Xue; 2014 Jan; 20(1):78-82. PubMed ID: 24527543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomechanical aspects of Peyronie's disease in development stages and following reconstructive surgeries.
    Gefen A; Elad D; Chen J
    Int J Impot Res; 2002 Oct; 14(5):389-96. PubMed ID: 12454691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microstructural disorders of tunica albuginea in patients affected by Peyronie's disease with or without erection dysfunction.
    Iacono F; Barra S; De Rosa G; Boscaino A; Lotti T
    J Urol; 1993 Dec; 150(6):1806-9. PubMed ID: 8230510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the paradigm for plaque development in Peyronie's disease.
    Mulhall JP
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S93-102. PubMed ID: 14551585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of tunica albuginea substitutes for the treatment of Peyronie's disease.
    Brannigan RE; Kim ED; Oyasu R; McVary KT
    J Urol; 1998 Mar; 159(3):1064-8. PubMed ID: 9474232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crural tunica albuginea autograft for corporoplasty: an experimental animal study of hemodynamic, histopathological, and molecular effects in the long term.
    Seyam RM; Mokhtar AA; Chishti MA; Ahmed M; Mourad WA; El-Sayed R; Hanash KA
    J Sex Med; 2007 Sep; 4(5):1277-90. PubMed ID: 17655656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peyronie's disease: etiology, medical, and surgical therapy.
    Hellstrom WJ; Bivalacqua TJ
    J Androl; 2000; 21(3):347-54. PubMed ID: 10819440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Straightening out Peyronie's: a medical and surgical approach to the patient.
    Trussell JC; Brien JC
    Can J Urol; 2008 Jun; 15(3):4047-55. PubMed ID: 18570708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-dimensional model of the penis for analysis of tissue stresses during normal and abnormal erection.
    Linder-Ganz E; Gefen A; Elad D; Chen J
    Ann N Y Acad Sci; 2007 Apr; 1101():464-76. PubMed ID: 17347335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peyronie's Disease.
    Taylor FL; Levine LA
    Urol Clin North Am; 2007 Nov; 34(4):517-34, vi. PubMed ID: 17983892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.